Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hydroxamate-containing cysteine and serine protease inhibitors

Hydroxamate-containing cysteine and serine protease inhibitors

US Patent 6686335 · Granted Feb 3, 2004

Estimated economic value: $20,750,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prodrugs of fencamfamine2024
Compositions and methods for determining the presence of active leukocyte cells 2021
Prodrugs of fencamfamine2020
Uracil derivatives as AXL and c-MET kinase inhibitors2018
Uracil derivatives as AXL and c-MET kinase inhibitors2017
Uracil derivatives as AXL and c-MET kinase inhibitors2016
Uracil derivatives as AXL and c-MET kinase inhibitors2015
Uracil derivatives as AXL and c-MET kinase inhibitors2015
Methods of treating disorders mediated by histamine H3 receptors using pyridazin2014
Aryl pyridazinone derivatives and their use as H3 receptor ligands2013
Pyrrolotriazines as ALK and JAK2 inhibitors2013
Pyridizinone derivatives and the use thereof as H3 inhibitors2012